Stempoint Capital’s Harrow HROW Stock Holding History

Stempoint Capital’s Portfolio HROW Stock Details HROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-57,619	Closed	-$2.78M	–	97
2025 Q3	$2.78M	Buy	+57,619	New	+$2.17M	0.56%	42

Other funds holding HROW

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCMF

Private Capital Management (Florida) Naples, Florida $1.14B AUM 34.86% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Stempoint Capital's HROW Position: Q4 2025 in Review

Stempoint Capital sold out of Harrow (HROW) in Q4 2025, closing a stake of 57,619 shares — an estimated $2.78M sold.

Stempoint Capital first reported a position in HROW in Q3 2025 and held it in 1 quarter. The position peaked at $2.78M in Q3 2025. 215 funds tracked by Wall St. Rank hold HROW as of Q4 2025.

Stempoint Capital reported no remaining Harrow position as of Q4 2025 after selling out during the quarter.
Stempoint Capital sold 57,619 Harrow shares in Q4 2025, an estimated $2.78M.
Stempoint Capital first reported a position in Harrow in Q3 2025 and held it in 1 quarter.
Stempoint Capital's Harrow position peaked at $2.78M in Q3 2025.
215 funds tracked by Wall St. Rank held Harrow as of Q4 2025.

Based on Stempoint Capital's 13F filing for Q4 2025, filed 17 Feb 2026.